- Home
- FEAM vs SYRS Comparison
FEAM vs SYRS Comparison
Compare FEAM & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEAM
- SYRS
- Stock Information
- Founded
- FEAM 2016
- SYRS 2011
- Country
- FEAM United States
- SYRS United States
- Employees
- FEAM N/A
- SYRS N/A
- Industry
- FEAM Major Chemicals
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- FEAM Industrials
- SYRS Health Care
- Exchange
- FEAM Nasdaq
- SYRS Nasdaq
- Market Cap
- FEAM 32.4M
- SYRS 7.1M
- IPO Year
- FEAM N/A
- SYRS 2016
- Fundamental
- Price
- FEAM $0.47
- SYRS $0.22
- Analyst Decision
- FEAM Strong Buy
- SYRS Hold
- Analyst Count
- FEAM 2
- SYRS 5
- Target Price
- FEAM $5.63
- SYRS $3.00
- AVG Volume (30 Days)
- FEAM 77.3K
- SYRS 2.6M
- Earning Date
- FEAM 02-12-2025
- SYRS 10-31-2024
- Dividend Yield
- FEAM N/A
- SYRS N/A
- EPS Growth
- FEAM N/A
- SYRS N/A
- EPS
- FEAM N/A
- SYRS N/A
- Revenue
- FEAM N/A
- SYRS $386,000.00
- Revenue This Year
- FEAM N/A
- SYRS N/A
- Revenue Next Year
- FEAM $773.56
- SYRS $1,011.11
- P/E Ratio
- FEAM N/A
- SYRS N/A
- Revenue Growth
- FEAM N/A
- SYRS N/A
- 52 Week Low
- FEAM $0.38
- SYRS $0.18
- 52 Week High
- FEAM $2.48
- SYRS $8.17
- Technical
- Relative Strength Index (RSI)
- FEAM 52.46
- SYRS 29.17
- Support Level
- FEAM $0.40
- SYRS $0.19
- Resistance Level
- FEAM $0.51
- SYRS $0.21
- Average True Range (ATR)
- FEAM 0.06
- SYRS 0.02
- MACD
- FEAM 0.01
- SYRS 0.07
- Stochastic Oscillator
- FEAM 68.99
- SYRS 20.53
About FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.